Rivaroxaban’s single daily dose may lead to higher bleeding risk than other DOACs
October 11, 2021
Corroborating previous studies, Iceland researchers report that rivaroxaban poses the highest risk of GI bleeding, compared with other DOACs.
Is the presence of enanthem a clue for COVID-19?
July 24, 2020
In the study, six of the patients presented with oral lesions, all of them located in the palate.
Psychiatry trainees drive COVID-19 palliative care in New York
July 21, 2020
The team managed 16 cases a day during the peak of New York's COVID-19 outbreak, operating on a rotating schedule of one to three shifts weekly.
Lifestyle changes may explain skin lesions in pandemic-era patients
July 2, 2020
"Dermatologists must be aware of the protean cutaneous findings that are possibly associated with COVID-19, even if our understanding of their origins remains incomplete."
For COVID-19 plus diabetes, glycemic control tops treatment list
June 15, 2020
Tight glucose control led to better results in patients with diabetes and COVID-19.
Match Day 2020: Online announcements replace celebrations, champagne
March 20, 2020
Match Day organizers look to Zoom, slide shows, email announcements, and other ways to engage future residents.